You can find more information on all of these metrics, and much more, on Zacks.com. Each was handpicked by a Zacks expert as the #1 favorite stock to gain +100% or more in 2024. While not all ...

Novo Nordisk stock tumbled Monday morning after disappointing trial results for its CagriSema weight-loss drug. Shares in rival Eli Lilly also sold off. Find out more: New trial data showed the ...

Natalie Venegas is a Weekend Reporter at Newsweek based in New York. Her focus is reporting on education, social justice issues, healthcare, crime and politics while specializing on marginalized ...

The most recent trading session ended with Enphase Energy (ENPH) standing at $63.71, reflecting a -1.73% shift from the previouse trading day's closing. The stock trailed the S&P 500, which ...

SANDUSKY, Ohio — The Siren’s Curse roller coaster won’t be the only new attraction coming to Cedar Point this summer as the Sandusky amusement park just revealed that two new water slides ...

as sales of its multiple sclerosis drug fell short of expectations. Cambridge, Mass.-based Biogen had net income of $266.8 million, or $1.83 a share, for the quarter, up from $249.7 million ...

Focus on the most impactful data that supports your narrative, and avoid cluttering slides with excessive figures.” Fortunately, you don’t have to format your visual layout from scratch. PowerPoint ...